TY - JOUR
T1 - Cumulative burden of financial hardship from medical bills across the spectrum of diabetes mellitus and atherosclerotic cardiovascular disease among non-elderly adults in the United States
AU - Mszar, Reed
AU - Grandhi, Gowtham R.
AU - Valero-Elizondo, Javier
AU - Caraballo, César
AU - Khera, Rohan
AU - Desai, Nihar
AU - Virani, Salim S.
AU - Blankstein, Ron
AU - Blaha, Michael J.
AU - Nasir, Khurram
N1 - Funding Information:
Dr Khera is supported by the National Heart, Lung, and Blood Institute (grant 5T32HL12524702) and the National Center for Advancing Translational Sciences (grant UL1TR001105) of the National Institutes of Health. Dr Virani has received research grants from the Department of Veterans Affairs, American Heart Association, American Diabetes Association, and World Heart Federation; and has received honoraria from the American College of Cardiology (Associate Editor for Innovations, acc.org). Dr Desai is supported by grant K12 HS023000-01 from the Agency for Healthcare Research and Quality; has received research funding from the Centers for Medicare & Medicaid Services to develop and maintain performance measures that are used for public reporting; and support from Johnson & Johnson and Medtronic, through Yale University, to develop methods of clinical trial data sharing. The remaining authors have no disclosures to report. Additionally, Dr. Nasir is supported by the Katz Academy of Translational Research.
Publisher Copyright:
© 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2020/5/18
Y1 - 2020/5/18
N2 - BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD) has a strong association with diabetes mellitus (DM), account-ing for approximately two thirds of deaths in this patient population. Many individuals with ASCVD and DM are vulnerable to financial hardship associated with treatment-related expenses. Therefore, we examined the burden of financial hardship from medical bills across the spectrum of ASCVD status with and without DM. METHODS AND RESULTS: Using data from the National Health Interview Survey from 2013 to 2017, we used logistic regression analysis to examine the association of ASCVD and DM status with financial hardship and an inability to pay medical bills from a representative sample of non-elderly adults in the United States. Our study population consisted of 121 672 individuals. Approximately 3.1% of the weighted population had ASCVD, 5.6% had DM, and 1.3% had both ASCVD and DM. Nearly 50% of individuals with ASCVD and DM reported financial hardship from medical bills (23% being unable to pay medical bills at all), whereas ≈28% of those with neither ASCVD nor DM reported financial hardship from medical bills (8% being unable to pay medical bills at all). Individuals with concurrent ASCVD and DM had the highest relative odds of expressing an inability to pay at all when compared with those with neither condition (odds ratio, 2.69; 95% CI, 2.21–3.28). CONCLUSIONS: Individuals with concurrent ASCVD and DM are at a disproportionately high risk of being unable to pay their medical bills. The findings provide strong evidence for developing more effective public health policies that protect vulnerable populations from financial hardship.
AB - BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD) has a strong association with diabetes mellitus (DM), account-ing for approximately two thirds of deaths in this patient population. Many individuals with ASCVD and DM are vulnerable to financial hardship associated with treatment-related expenses. Therefore, we examined the burden of financial hardship from medical bills across the spectrum of ASCVD status with and without DM. METHODS AND RESULTS: Using data from the National Health Interview Survey from 2013 to 2017, we used logistic regression analysis to examine the association of ASCVD and DM status with financial hardship and an inability to pay medical bills from a representative sample of non-elderly adults in the United States. Our study population consisted of 121 672 individuals. Approximately 3.1% of the weighted population had ASCVD, 5.6% had DM, and 1.3% had both ASCVD and DM. Nearly 50% of individuals with ASCVD and DM reported financial hardship from medical bills (23% being unable to pay medical bills at all), whereas ≈28% of those with neither ASCVD nor DM reported financial hardship from medical bills (8% being unable to pay medical bills at all). Individuals with concurrent ASCVD and DM had the highest relative odds of expressing an inability to pay at all when compared with those with neither condition (odds ratio, 2.69; 95% CI, 2.21–3.28). CONCLUSIONS: Individuals with concurrent ASCVD and DM are at a disproportionately high risk of being unable to pay their medical bills. The findings provide strong evidence for developing more effective public health policies that protect vulnerable populations from financial hardship.
KW - Atherosclerotic cardiovascular disease
KW - Diabetes mellitus
KW - Financial hardship
KW - Medical bills
KW - Outcomes
UR - http://www.scopus.com/inward/record.url?scp=85084936571&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084936571&partnerID=8YFLogxK
U2 - 10.1161/JAHA.119.015523
DO - 10.1161/JAHA.119.015523
M3 - Article
C2 - 32394783
AN - SCOPUS:85084936571
SN - 2047-9980
VL - 9
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 10
M1 - e015523
ER -